Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer.

Loading...
Thumbnail Image

Embargo End Date

ICR Authors

Authors

Esteves, F
Xavier, JM
Ford, AM
Rocha, C
Pharoah, PDP
Caldas, C
Chin, S-F
Maia, A-T

Document Type

Journal Article

Date

2022-06-27

Date Accepted

2022-05-20

Abstract

INTRODUCTION: Translation of genome-wide association study (GWAS) findings into preventive approaches is challenged by the identification of the causal risk variants and the understanding of the biological mechanisms by which they act. We present using allelic expression (AE) ratios to perform quantitative case-control analysis as a novel approach to identify risk associations, causal regulatory variants, and target genes. METHODS: Using the breast cancer (BC) risk locus 17q22 to validate this approach, we measured AE ratios in normal breast tissue samples from controls and cases, as well as from unmatched blood samples. Then we used in-silico and in-vitro analysis to map and functionally characterised candidate causal variants. RESULTS: We found a significant shift in the AE patterns of STXBP4 (rs2628315) and COX11 (rs17817901) in the normal breast tissue of cases and healthy controls. Preferential expression of the G-rs2628315 and A-rs17817901 alleles, more often observed in cases, was associated with an increased risk for BC. Analysis of blood samples from cases and controls found a similar association. Furthermore, we identified two putative cis-regulatory variants - rs17817901 and rs8066588 - that affect a miRNA and a transcription factor binding site, respectively. CONCLUSION: We propose causal variants and target genes for the 17q22 BC risk locus and show that using AE ratios in case-control association studies is helpful in identifying risk and mapping causal variants.

Citation

European Journal of Cancer, 2022, 172 pp. 146 - 157

Source Title

European Journal of Cancer

Publisher

ELSEVIER SCI LTD

ISSN

0959-8049

eISSN

1879-0852
1879-0852

Collections

Research Team

Biol Childhood Leukaemia

Notes